Cartesian Therapeutics, Inc. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -521.05%-433.89%-441.53%-31,098.07%-7,249.83%-828.97%-414.99%-11.43%31.39%-917.97%-198.23%
EBIT Margin -506.55%-420.96%-428.92%-30,813.53%-7,200.66%-785.61%-342.36%-5.40%13.12%-332.32%-112.81%
EBITDA Margin -531.61%-437.27%-442.19%-31,508.70%-7,250.61%-828.46%-415.23%-30.20%31.94%-845.07%-199.02%
Operating Margin -506.55%-420.96%-428.92%-30,813.53%-7,200.66%-785.61%-342.36%-5.40%13.12%-332.32%-112.81%
Net Margin -538.55%-540.83%-504.47%-31,556.04%-7,235.44%-828.97%-414.99%-30.19%31.94%-844.91%-198.97%
FCF Margin -424.77%-393.05%-251.68%-25,487.44%-6,649.50%-771.03%205.25%-72.25%-29.64%-197.53%-84.21%
Efficiency
Assets Average 66.06M95.20M72.79M72.03M132.50M162.66M162.88M235.47M370.04M
Equity Average -102.12M-30.77M53.39M23.20M1.49M-4.80M2.26M58.17M-173.18M-223.49M
Invested Capital -87.75M-116.49M59.02M51.81M15.97M27.30M-18.01M28.48M102.30M-411.88M-6.80M
Asset Utilization Ratio 0.120.000.010.090.130.520.680.110.11
Leverage & Solvency
Interest Coverage Ratio -27.90-26.69-27.67-52.89-43.52-34.53-36.52-1.624.80-30.50
Debt to Equity -0.100.220.41-3.952.25-1.381.140.28-0.06
Debt Ratio 0.280.130.210.480.190.150.160.160.09
Equity Ratio -2.720.620.51-0.120.08-0.110.140.57-1.44-0.02
Times Interest Earned -27.90-26.69-27.67-52.89-43.52-34.53-36.52-1.624.80-30.50
Valuation
Enterprise Value -16.59M-36.46M227.82M122.56M22.27M24.54M188.65M252.22M38.32M30.09M242.57M
Market Capitalization 311.96M219.12M59.67M114.71M327.33M380.28M172.93M107.00M455.18M
Return Ratios
Return on Sales -5.21%-4.34%-4.42%-310.98%-72.50%-8.29%-4.15%-0.30%0.32%-8.45%-1.99%
Return on Capital Employed -0.66%-0.76%-1.73%-1.41%-1.12%-0.05%0.11%-0.52%-0.13%
Return on Invested Capital 0.51%
Return on Assets -0.54%-0.68%-0.90%-0.77%-0.52%-0.16%0.22%-0.93%-0.21%
Return on Equity 0.26%1.16%-1.21%-2.82%-37.16%14.34%-11.38%0.61%1.27%0.35%